TrialBlood cancer journal2016

A phase 2 study of bortezomib, cyclophosphamide, pegylated liposomal doxorubicin and dexamethasone for newly diagnosed multiple myeloma.

P S Becker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.